Unique ID issued by UMIN | UMIN000014634 |
---|---|
Receipt number | R000016971 |
Scientific Title | Clinical Study of TC-V in Patients with Chronic GVHD |
Date of disclosure of the study information | 2014/07/28 |
Last modified on | 2016/11/18 13:00:10 |
Clinical Study of TC-V in Patients with Chronic GVHD
Clinical Study of TC-V in Patients with Chronic GVHD
Clinical Study of TC-V in Patients with Chronic GVHD
Clinical Study of TC-V in Patients with Chronic GVHD
Japan |
Chronic GVHD after hematopoietic stem cell transplantation
Hematology and clinical oncology |
Others
NO
To evaluate efficacy and safety of conducting ECP therapy using TC-V in patients with chronic GVHD
Safety,Efficacy
To evaluate based on the changes the organ score and the changes in steroid level at prior to ECP therapy and that at Week 24 of ECP therapy.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
ECP therapy
Not applicable |
Not applicable |
Male and Female
1. Patients who were diagnosed with chronic GVHD according to GVHD guideline after the transplantation of hematopoietic stem cell derived from related donor or unrelated donor.
2. Patients who are judged to be steroid-resistant, steroid-dependent, or steroid-intolerant.
3. Patients who received an explanation for clinical study and submitted a written informed consent.
1. Patients who are allergic or hypersensitive to methoxsalen.
2. Patients who cannot tolerate the changes in blood flow associated with ECP therapy.
3. Patients who are hypersensitive or allergic to both heparin and Acid Citrate Dextrose Solution (ACD) (Patients who are hypersensitive or allergic only one of them are not excluded).
4. Patients who are pregnant, patients who have possibility of being pregnant, or patients who are breastfeeding.
5. Patients who cannot use appropriate contraceptive method throughout the study period.
6. Patients who are infected with human immunodeficiency virus (HIV) or active hepatitis B.
7. Patients with diseases associated with aphakia or photosensitivity (such as systemic lupus erythematosus, porphyria, and albinism) (Non-sighted patients with aphakia are not excluded).
8. Patients who are enrolled in other clinical studies not including a treatment outcome study.
9. Patients with previous experience with ECP therapy.
10. Patients with infectious disease which requires treatment.
11. Patients in whom the blood vessel access is difficult.
12. Patients whose kidney function was worsened within past three months (showing serum creatinine concentration of over 3.0 mg/dL).
13. Patients with life expectancy of less than 6 months.
14. Patients in whom the white blood cell count and platelet count are significantly decreased (white blood cell count of less than 1000/micro L and platelet count of less than 25000/micro L).
15. Patients with Karnofsky Performance Scale of less than 30.
16. Patients with active bleeding in gastrointestinal tract (GI bleeding).
17. Patients who received new drug or increased dose of drug within 14 days for the therapy to treat GVHD.
18. Patients in whom the control of primary disease is difficult.
19. Other patients who are judged by physician as being unsuitable.
10
1st name | |
Middle name | |
Last name | Okamoto, Shinichiro |
Keio University Hospital
Hematology
35 Shinano-machi, Shinjuku-ku, Tokyo
03-3353-1211
okamoto@a7.keio.jp
1st name | |
Middle name | |
Last name | Kohama, Ichiro |
Vorpal Technologies K.K.
Regulatory Research Development & Quality Managemant
4-15-1 Akasaka, Minato-ku, Tokyo
03-5544-8340
kohama@vorpaltechnologies.com
Vorpal Technologies K.K.
Vorpal Technologies K.K.
Profit organization
NO
慶應義塾大学病院(東京都)/ Keio University Hospital (Tokyo)
名古屋第一赤十字病院(名古屋)/ Japanese Red Cross Nagoya Daiichi Hospital (Nagoya)
北海道大学病院(北海道)/ Hokkaido University Hospital (Hokkaido)
2014 | Year | 07 | Month | 28 | Day |
Unpublished
Completed
2013 | Year | 04 | Month | 07 | Day |
2014 | Year | 07 | Month | 28 | Day |
2016 | Year | 06 | Month | 15 | Day |
2014 | Year | 07 | Month | 24 | Day |
2016 | Year | 11 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016971
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |